Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Annals of the Rheumatic Diseases|February 24, 2023
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumaticaChristian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, et al.
Clinical and Experimental Rheumatology|April 12, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patientsSabrina Arnold, Pia Wallmeier, Arlette Tais, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis with Polyangiitis: Findings from a Large European CohortMatthias Papo, Pauline Martinot, Renato A Sinico, et al.
Annals of the Rheumatic Diseases|July 30, 2025
A glossary of signs and symptoms of giant cell arteritisMedha L Soowamber, Milena Bond, Zahi Touma, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Nature Communications|November 14, 2019
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA statusPaul A Lyons, James E Peters, Federico Alberici, et al.
Pageof 16